Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-04-19

THE DEVELOPMENT OF IMPROVED BIOCOMPATIBLE MATERIALS FOR UROLOGICAL AND OTHER MEDICAL DEVICES

Objetivo


A novel in vitro encrustation model, representing a considerable advance on the established practice, was developed and used in the project to assess the calculogenicity of material sample surfaces and devices in contact with urine. A range of polymer classes and device manufacturing approaches have been examined. From this work, plasma coating with functionalised hyaluronic acid polymers has emerged as the system of choice for the fabrication of improved stents for urological applications. A novel ureteric stent has been designed, prototypes manufactured and a patent application filed. A consortium if forming and an exploitation plan is evolving on the basis of these successes.
Polymeric materials are widely used as implants in the treatment of human disease. Two major problems associated with urological implants are the development of encrustations and urinary tract infections. These frequently lead to costly extended or repeated hospitalisation. A further need in urology, as in other clinical areas, is for long-term indwelling devices. Here, the problems rising from such lack of biocompatibility are exacerbated. The principal aim of the proposed programme is to design, synthesise, develop and test a range of novel polymeric materials with enhanced biocompatibility, initially for urological use.

Further aims are:

i) to improve understanding, by systematic investigation, of struture-property relationships leading to the establishment of design criteria for polymeric materials used in a particular medical application;

ii) to provide, through the systematic assembly and interpretation of data, a basis for the development of standards.

Emphasis will be placed on an integrated and extensive characterisation regime, encompassing physical, mechanical and surface properties and biological testing in vitro and in vivo. The most promising materials will be used to fabricate prototype devices (tubing, catheters, stents) which, following further, similar characterisation will undergo clinical tests.

Programa(s)

Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.

Tema(s)

Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.

Convocatoria de propuestas

Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.

Datos no disponibles

Régimen de financiación

Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.

CSC - Cost-sharing contracts

Coordinador

Kodak Ltd
Aportación de la UE
Sin datos
Dirección
Headstone Drive
HA1 1PF Harrow
Reino Unido

Ver en el mapa

Coste total

Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.

Sin datos

Participantes (6)

Mi folleto 0 0